Screener
ArriVent BioPharma, Inc. AVBP Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $1.02B.
The source filing: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-058650
FAQ
- What is ArriVent BioPharma, Inc.'s market capitalization?
- ArriVent BioPharma, Inc. (AVBP) reported market capitalization of $1.02B in Q1 2026.
- How has ArriVent BioPharma, Inc.'s market capitalization changed year-over-year?
- ArriVent BioPharma, Inc.'s market capitalization increased by 62.1% year-over-year, from $628.96M to $1.02B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about ArriVent BioPharma, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude